|Articles|March 1, 2000

Creating an Optimal Strategy for Managing Hypertension
Volume 6
Issue 4 Suppl

The Impact of the New HEDIS Guidelines: Practical Considerations

Author(s)Earl P. Steinberg, MD, MPP

Download PDF: The Impact of the New HEDIS Guidelines: Practical Considerations

Articles in this issue

almost 26 years ago

Article

Participating Faculty

almost 26 years ago

Article

Introduction

almost 26 years ago

Article

Clinical Overview of Antihypertensive Classes - Clinically Relevant Differences: Myths or Facts?

almost 26 years ago

Article

Critical Overview of Antihypertensive Therapies: What is Preventing Us from Getting There?

almost 26 years ago

Article

Impact and Risks of Untreated Hypertension on Managed Care

almost 26 years ago

Article

Closing Remarks

almost 26 years ago

Article

CE Quiz

almost 26 years ago

Article

Selected Abstracts

almost 26 years ago

Article

Bibliography

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Subscribe Now!

Related Content

The Health Information Technology Special Issue: Tracking Expansion Across Settings, Technologies, and Stakeholders

ByNate C. Apathy, PhD

January 27th 2026

Building Trust: Public Priorities for Health Care AI Labeling

ByMorgan L. Sielaff, BS,Jodyn Platt, PhD, MPH,Sean Tan, MPP,Kerry A. Ryan, MA,Paige Nong, PhD,Sharon L. R. Kardia, PhD

January 27th 2026

Ambient AI Tool Adoption in US Hospitals and Associated Factors

ByFreddie Yang, MA,Ilana Graetz, PhD

January 27th 2026

Motivating and Enabling Factors Supporting Targeted Improvements to Hospital-SNF Transitions

ByTaylor I. Bucy, PhD,John P. McHugh, PhD,Dori A. Cross, PhD

January 26th 2026

Specialty and Operator Status Influence Electronic Health Record Use Variation

ByPhillip D. Jenkins, MD,Gary Grunkemeier, PhD,Elizabeth Weirich, DO,An Dinh, MS,Ruchi Thanawala, MD, MS,Jeffrey A. Gold, MD,Julie Doberne, MD, PhD

January 22nd 2026

Latest CME

Online Article

Innovations in Medicine: 2024 Lineup of New and Approved Specialty Drugs

2.0 Credits / General Pharmacy

The Impact of the New HEDIS Guidelines: Practical Considerations

Articles in this issue

Newsletter

Related Content

The Health Information Technology Special Issue: Tracking Expansion Across Settings, Technologies, and Stakeholders

Building Trust: Public Priorities for Health Care AI Labeling

Ambient AI Tool Adoption in US Hospitals and Associated Factors

Motivating and Enabling Factors Supporting Targeted Improvements to Hospital-SNF Transitions

Specialty and Operator Status Influence Electronic Health Record Use Variation

Latest CME

Innovations in Medicine: 2024 Lineup of New and Approved Specialty Drugs

Trending on AJMC

AAP Breaks With CDC, Maintains Broader 2026 Childhood and Adolescent Vaccine Schedule

CLL Breakthrough: 100% Efficacy Reported for VenR Retreatment

AI-Supported Mammography Caught More Cancers During Screening

Combination Therapy, Biologics, and Surgery Redefine HS Care in 2026

Trulicity, Botox Headline Drugs Included in the Third Cycle of Medicare Price Negotiations